230 related articles for article (PubMed ID: 28399096)
21. Treatment with α-Lipoic Acid over 16 Weeks in Type 2 Diabetic Patients with Symptomatic Polyneuropathy Who Responded to Initial 4-Week High-Dose Loading.
Garcia-Alcala H; Santos Vichido CI; Islas Macedo S; Genestier-Tamborero CN; Minutti-Palacios M; Hirales Tamez O; García C; Ziegler D
J Diabetes Res; 2015; 2015():189857. PubMed ID: 26345602
[TBL] [Abstract][Full Text] [Related]
22. Alpha-Lipoic Acid for Treatment of Diabetic Peripheral Neuropathy.
Bartkoski S; Day M
Am Fam Physician; 2016 May; 93(9):786. PubMed ID: 27175957
[No Abstract] [Full Text] [Related]
23. A systematic review and meta-analysis of α-lipoic acid in the treatment of diabetic peripheral neuropathy.
Han T; Bai J; Liu W; Hu Y
Eur J Endocrinol; 2012 Oct; 167(4):465-71. PubMed ID: 22837391
[TBL] [Abstract][Full Text] [Related]
24. Differential efficacy of methylcobalamin and alpha-lipoic acid treatment on symptoms of diabetic peripheral neuropathy.
Han Y; Wang M; Shen J; Zhang Z; Zhao M; Huang J; Chen Y; Chen Z; Hu Y; Wang Y
Minerva Endocrinol; 2018 Mar; 43(1):11-18. PubMed ID: 27901334
[TBL] [Abstract][Full Text] [Related]
25. Insights on the Use of α-Lipoic Acid for Therapeutic Purposes.
Salehi B; Berkay Yılmaz Y; Antika G; Boyunegmez Tumer T; Fawzi Mahomoodally M; Lobine D; Akram M; Riaz M; Capanoglu E; Sharopov F; Martins N; Cho WC; Sharifi-Rad J
Biomolecules; 2019 Aug; 9(8):. PubMed ID: 31405030
[TBL] [Abstract][Full Text] [Related]
26. The function of endogenous protective systems in patients with insulin-dependent diabetes mellitus and polyneuropathy: effect of antioxidant therapy.
Strokov IA; Manukhina EB; Bakhtina LY; Malyshev IY; Zoloev GK; Kazikhanova SI; Ametov AS
Bull Exp Biol Med; 2000 Oct; 130(10):986-90. PubMed ID: 11177301
[TBL] [Abstract][Full Text] [Related]
27. The effect of alpha-lipoic acid on the neurovascular reflex arc in patients with diabetic neuropathy assessed by capillary microscopy.
Haak ES; Usadel KH; Kohleisen M; Yilmaz A; Kusterer K; Haak T
Microvasc Res; 1999 Jul; 58(1):28-34. PubMed ID: 10388600
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of α-lipoic acid in diabetic neuropathy.
Papanas N; Ziegler D
Expert Opin Pharmacother; 2014 Dec; 15(18):2721-31. PubMed ID: 25381809
[TBL] [Abstract][Full Text] [Related]
29. Switching from pathogenetic treatment with alpha-lipoic acid to gabapentin and other analgesics in painful diabetic neuropathy: a real-world study in outpatients.
Ruessmann HJ;
J Diabetes Complications; 2009; 23(3):174-7. PubMed ID: 18403218
[TBL] [Abstract][Full Text] [Related]
30. The role of alpha-lipoic acid in diabetic polyneuropathy treatment.
Bureković A; Terzić M; Alajbegović S; Vukojević Z; Hadzić N
Bosn J Basic Med Sci; 2008 Nov; 8(4):341-5. PubMed ID: 19125705
[TBL] [Abstract][Full Text] [Related]
31. Effects of alpha-lipoic acid on microcirculation in patients with peripheral diabetic neuropathy.
Haak E; Usadel KH; Kusterer K; Amini P; Frommeyer R; Tritschler HJ; Haak T
Exp Clin Endocrinol Diabetes; 2000; 108(3):168-74. PubMed ID: 10926311
[TBL] [Abstract][Full Text] [Related]
32. Advances in the management of diabetic neuropathy.
Várkonyi T; Körei A; Putz Z; Martos T; Keresztes K; Lengyel C; Nyiraty S; Stirban A; Jermendy G; Kempler P
Minerva Med; 2017 Oct; 108(5):419-437. PubMed ID: 28541026
[TBL] [Abstract][Full Text] [Related]
33. [The use of dipyridamole (curantyl) in combination with alpha-lipoic acid in the treatment of diabetic neuropathy with retinopathy].
Al-Zamil MKh
Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(7):23-6. PubMed ID: 18833114
[TBL] [Abstract][Full Text] [Related]
34. Alpha-Lipoic Acid and Glucose Metabolism: A Comprehensive Update on Biochemical and Therapeutic Features.
Capece U; Moffa S; Improta I; Di Giuseppe G; Nista EC; Cefalo CMA; Cinti F; Pontecorvi A; Gasbarrini A; Giaccari A; Mezza T
Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615676
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of antioxidant treatment with α-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial.
Ziegler D; Low PA; Litchy WJ; Boulton AJ; Vinik AI; Freeman R; Samigullin R; Tritschler H; Munzel U; Maus J; Schütte K; Dyck PJ
Diabetes Care; 2011 Sep; 34(9):2054-60. PubMed ID: 21775755
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of the analgesic effect of ɑ-lipoic acid in treating pain disorders: A systematic review and meta-analysis of randomized controlled trials.
Cassanego G; Rodrigues P; De Freitas Bauermann L; Trevisan G
Pharmacol Res; 2022 Mar; 177():106075. PubMed ID: 35026405
[TBL] [Abstract][Full Text] [Related]
37. Alpha-lipoic acid: a multifunctional antioxidant that improves insulin sensitivity in patients with type 2 diabetes.
Evans JL; Goldfine ID
Diabetes Technol Ther; 2000; 2(3):401-13. PubMed ID: 11467343
[TBL] [Abstract][Full Text] [Related]
38. α-Lipoic acid, diabetic neuropathy, and Nathan's prophecy.
Papanas N; Maltezos E
Angiology; 2012 Feb; 63(2):81-3. PubMed ID: 22253286
[TBL] [Abstract][Full Text] [Related]
39. Alpha lipoic acid combined with epalrestat: a therapeutic option for patients with diabetic peripheral neuropathy.
Wang X; Lin H; Xu S; Jin Y; Zhang R
Drug Des Devel Ther; 2018; 12():2827-2840. PubMed ID: 30233145
[TBL] [Abstract][Full Text] [Related]
40. Alpha-lipoic acid may improve symptomatic diabetic polyneuropathy.
Tang J; Wingerchuk DM; Crum BA; Rubin DI; Demaerschalk BM
Neurologist; 2007 May; 13(3):164-7. PubMed ID: 17495764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
